{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T11:44:13Z","timestamp":1747827853770,"version":"3.37.0"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ijcard.2025.133030","type":"journal-article","created":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T23:08:37Z","timestamp":1738451317000},"page":"133030","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Disopyramide for symptomatic obstructive hypertrophic cardiomyopathy"],"prefix":"10.1016","volume":"423","author":[{"given":"Mark V.","family":"Sherrid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Massera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2025.133030_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2024.132913","article-title":"The effect of disopyramide therapy on functional capacity improvement in patients with obstructive hypertrophic cardiomyopathy","volume":"421","author":"Guler","year":"2025","journal-title":"Int. J. Cardiol."},{"issue":"16","key":"10.1016\/j.ijcard.2025.133030_bb0010","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJM198210143071607","article-title":"Muscular subaortic stenosis: hemodynamic and clinical improvement after disopyramide","volume":"307","author":"Pollick","year":"1982","journal-title":"N. Engl. J. Med."},{"issue":"16","key":"10.1016\/j.ijcard.2025.133030_bb0015","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/0002-9149(88)90553-X","article-title":"Oral disopyramide therapy for obstructive hypertrophic cardiomyopathy","volume":"62","author":"Sherrid","year":"1988","journal-title":"Am. J. Cardiol."},{"issue":"8","key":"10.1016\/j.ijcard.2025.133030_bb0020","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.jacc.2005.01.012","article-title":"Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy","volume":"45","author":"Sherrid","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"issue":"22","key":"10.1016\/j.ijcard.2025.133030_bb0025","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1016\/j.jacc.2011.08.040","article-title":"Long-term survival in patients with resting obstructive hypertrophic cardiomyopathy comparison of conservative versus invasive treatment","volume":"58","author":"Ball","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.ijcard.2025.133030_bb0030","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1161\/CIRCHEARTFAILURE.112.000122","article-title":"Treatment of obstructive hypertrophic cardiomyopathy symptoms and gradient resistant to first-line therapy with beta-blockade or verapamil","volume":"6","author":"Sherrid","year":"2013","journal-title":"Circ. Heart Fail."},{"issue":"6","key":"10.1016\/j.ijcard.2025.133030_bb0035","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.pcad.2012.04.003","article-title":"A primer of disopyramide treatment of obstructive hypertrophic cardiomyopathy","volume":"54","author":"Sherrid","year":"2012","journal-title":"Prog. Cardiovasc. Dis."},{"issue":"7","key":"10.1016\/j.ijcard.2025.133030_bb0040","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jacbts.2019.06.004","article-title":"Electrophysiological and contractile effects of Disopyramide in patients with obstructive hypertrophic cardiomyopathy: a translational study","volume":"4","author":"Coppini","year":"2019","journal-title":"JACC Basic Transl. Sci."},{"key":"10.1016\/j.ijcard.2025.133030_bb0045","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.037639","article-title":"Disopyramide revisited for treatment of symptomatic obstructive hypertrophic cardiomyopathy: efficacy and safety in patients treated for at least 5 years","volume":"14","author":"Massera","year":"2025","journal-title":"J. Am. Heart Assoc."},{"issue":"10","key":"10.1016\/j.ijcard.2025.133030_bb0050","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/j.hrthm.2024.04.055","article-title":"Incidence of newly recognized atrial fibrillation in patients with obstructive hypertrophic cardiomyopathy treated with Mavacamten","volume":"21","author":"Castrichini","year":"2024","journal-title":"Heart Rhythm."},{"issue":"25","key":"10.1016\/j.ijcard.2025.133030_bb0055","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1016\/j.jacc.2021.07.065","article-title":"Randomized trial of metoprolol in patients with obstructive hypertrophic cardiomyopathy","volume":"78","author":"Dybro","year":"2021","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527325000737?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527325000737?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T07:01:12Z","timestamp":1739343672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527325000737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":11,"alternative-id":["S0167527325000737"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2025.133030","relation":{},"ISSN":["0167-5273"],"issn-type":[{"type":"print","value":"0167-5273"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disopyramide for symptomatic obstructive hypertrophic cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2025.133030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2024.132913","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"133030"}}